Terrance Williams
Terrance Williams's purchase track record
Terrance Williams has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/2/2021 | EHC | $20K | +16.2% | +13.4% | -8.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Allstate reports Q3 catastrophe losses and supports hurricane customers. Allstate disclosed estimated total catastrophe losses for the third quarter of $1.65 billion, or $1.3 billion after tax. The insurer also highlighted its assistance to customers affected by Hurricane Isaias, emphasizing continued claims support. Despite a broader market decline, Allstate’s shares rose, aligning with a sector‑wide gain in financial stocks observed later in the day.
Transaction History
| EHC | ▲ Buy | Grant | 29 | $0 | 7/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,634 | $0 | 5/7/2026 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 4/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 28 | $0 | 1/15/2026 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 10/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 7/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,424 | $0 | 5/1/2025 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 4/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 25 | $0 | 1/15/2025 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 10/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 7/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 1,978 | $0 | 5/2/2024 | View on chart |
| EHC | ▲ Buy | Grant | 21 | $0 | 4/15/2024 | View on chart |
| EHC | ▲ Buy | Grant | 24 | $0 | 1/16/2024 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 10/16/2023 | View on chart |
| EHC | ▲ Buy | Grant | 25 | $0 | 7/17/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,385 | $0 | 5/4/2023 | View on chart |
| EHC | ▲ Buy | Grant | 22 | $0 | 4/17/2023 | View on chart |
| ALL | ▲ Buy | Grant | 7,185 | $0 | 2/19/2023 | View on chart |
| ALL | ▼ Sell | Tax Withholding | 3,327 | $449K | 2/19/2023 | View on chart |
| ALL | ▲ Buy | Option Exercise | 12,032 | $0 | 2/5/2023 | View on chart |
| ALL | ▼ Sell | Tax Withholding | 4,470 | $587K | 2/5/2023 | View on chart |
| EHC | ▲ Buy | Grant | 22 | $0 | 1/17/2023 | View on chart |
| EHC | ▲ Buy | Grant | 27 | $0 | 10/17/2022 | View on chart |
| EHC | ▲ Buy | Grant | 50 | $0 | 7/20/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,226 | $0 | 5/5/2022 | View on chart |
| EHC | ▲ Buy | Grant | 20 | $0 | 4/18/2022 | View on chart |
| EHC | ▲ Buy | Grant | 23 | $0 | 1/18/2022 | View on chart |
| EHC | ▲ Buy | Open Market | 354 | $20K | 12/2/2021 | View on chart |
| EHC | ▲ Buy | Grant | 21 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.